Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tracing the transmission of carbapenem-resistant Enterobacteriales at the patient:ward environmental nexus

ABSTRACT: Using genomics to identify hospital transmission of carbapenem-resistant Enterobacteriales

PROVIDER: PRJEB76684 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	ERR13298100.fastq.gz	Fastqsanger.gz
	ERR13298101.fastq.gz	Fastqsanger.gz
	ERR13298102.fastq.gz	Fastqsanger.gz
	ERR13298103.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 87

Similar Datasets

Enterobacteriales-OXA48

Project description:Samples from an OXA48 resistant Enterobacteriales in an hospital ward

| PRJEB39204 | ENA

Enterobacteriales

Project description:A collection of carbapenemase producing Enterobacteriales from an outbreak investigation Raw sequence reads

| PRJNA534306 | ENA

transmission

Project description:Microbiota transmission

| PRJEB28216 | ENA

Genomic characterization of 16S rRNA methytransferase-producing Enterobacteriales isolated in a Bulgarian cancer hospital

Project description:Genomic characterization of 16S rRNA methytransferase-producing Enterobacteriales isolated in a Bulgarian cancer hospital

| PRJEB70839 | ENA

Clinical and Microbiological Characterization of Carbapenem-Resistant <i>Enterobacteriales</i>: A Prospective Cohort Study.

Project description:Aim: We aim to depict the clinicoepidemiological and molecular information of carbapenem-resistant Enterobacteriales (CRE) in Chongqing, China. Methods: We performed a prospective, observational cohort study, recruiting inpatients diagnosed with CRE infections from June 1, 2018, to December 31, 2019. We carried out strain identification and molecular characterization of CRE. eBURST analysis was conducted to assess the relationships among the different isolates on the basis of their sequence types (STs) and associated epidemiological data using PHYLOViZ. Clinical parameters were compared between the carbapenemase-producing Enterobacteriales (CPE) and non-CPE group. Findings: 128 unique CRE isolates from 128 patients were collected during the study period: 69 (53.9%) CPE and 59 (46.1%) non-CPE. The majority of CPE isolates were bla KPC-2 (56.5%), followed by bla NDM (39.1%) and bla IMP (5.8%). Klebsiella pneumoniae carbapenemase (KPC)-producing clonal group 11 Klebsiella pneumoniae (K. pneumoniae) was the most common CPE. Antibiotic resistance was more frequent in the CPE group than in the non-CPE group. Independent predictors for CPE infection were ICU admission and hepatobiliary system diseases. Although, there was no significant difference in desirability of outcome ranking (DOOR) outcomes between the two groups. At 30 days after index culture, 35 (27.3% ) of these patients had died. Conclusion: CRE infections were related to high mortality and poor outcomes, regardless of CRE subgroups. CPE were associated with prolonged ICU stays and had different clinical and microbiological characteristics than non-CPE. The identification of CPE/non-CPE and CRE resistance mechanisms is essential for better guidance of the clinical administration of patients with CRE infections.

| S-EPMC8531092 | biostudies-literature

p-OXA48-ST399

Project description:Carbapenem resistant enterobacteriales in a hospital ward

| PRJEB38983 | ENA

Transmission

Project description:The person-to-person transmission landscape of the gut and oral microbiomes

| PRJEB45799 | ENA

Pseudomonas aeruginosa transmission from sink to patient

Project description:In vitro single nucleotide variability applied in vivo: drain to patient transmission of multidrug-resistant Pseudomonas aeruginosa

| PRJEB32583 | ENA

Streptococcus pyogenes transmission study

Project description:Streptococcus pyogenes transmission study

| PRJEB2104 | ENA

OOCYSTSTOP - blocking malaria transmission

Project description:The goal of OOCYSTOP is based on an innovative concept to block malaria transmission by development of new drugs that will be delivered (1) to oocysts in infected mosquitoes and (2) to early stages in human infection by the sporozoite

2023-02-28 | MSV000091377 | MassIVE

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data